tiprankstipranks
Trending News
More News >
Silexion Therapeutics Corp (SLXN)
:SLXN
US Market

Silexion Therapeutics (SLXN) Cash flow

Compare
212 Followers

Silexion Therapeutics Cash Flow

SLXN's free cash flow for Q3 2025 was $-2.84M. For the 2025 fiscal year, SLXN's free cash flow was decreased by $-3.88M and operating cash flow was $-2.84M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -8.40M$ -4.53M$ -3.33M$ -1.41M$ -75.00K
Investing Cash Flow
$ -22.00K$ 573.00K$ -524.00K$ 0.00$ 0.00
Financing Cash Flow
$ 5.10M$ 522.00K$ 2.75M$ 116.40M$ 126.70K
End Cash Position
$ 1.27M$ 4.64M$ 8.31M$ 38.94K$ 51.70K
Free Cash Flow
$ -8.42M$ -4.54M$ -3.38M$ -1.41M$ -75.00K
Currency in USD

Silexion Therapeutics Cash Flow